Your browser doesn't support javascript.
loading
Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
Polyzos, Konstantinos A; Ovchinnikova, Olga; Berg, Martin; Baumgartner, Roland; Agardh, Hanna; Pirault, John; Gisterå, Anton; Assinger, Alice; Laguna-Fernandez, Andres; Bäck, Magnus; Hansson, Göran K; Ketelhuth, Daniel F J.
Afiliación
  • Polyzos KA; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Ovchinnikova O; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Berg M; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Baumgartner R; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Agardh H; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Pirault J; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Gisterå A; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Assinger A; Institute of Physiology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Laguna-Fernandez A; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Bäck M; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Hansson GK; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden.
  • Ketelhuth DF; Department of Medicine, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, L8:03, Karolinska University Hospital, Stockholm S-17176, Sweden daniel.ketelhuth@ki.se.
Cardiovasc Res ; 106(2): 295-302, 2015 May 01.
Article en En | MEDLINE | ID: mdl-25750192
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triptófano / Aterosclerosis / Indolamina-Pirrol 2,3,-Dioxigenasa / Quinurenina Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2015 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triptófano / Aterosclerosis / Indolamina-Pirrol 2,3,-Dioxigenasa / Quinurenina Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2015 Tipo del documento: Article País de afiliación: Suecia